NGL Fine-Chem schedules Q4FY26 earnings call on May 25

1 min read     Updated on 20 May 2026, 05:34 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

NGL Fine-Chem Limited has scheduled an earnings conference call for May 25, 2026, to review the operational and financial performance for Q4 and FY26. The meeting, compliant with SEBI regulations, will be led by Managing Director Mr Rahul Nachane and Whole-Time Director & CFO Mr Rajesh Lawande. Investors can join via toll-free numbers or a registration link available on the company website.

powered bylight_fuzz_icon
40762751

*this image is generated using AI for illustrative purposes only.

ngl fine chem has announced the schedule for its earnings conference call to discuss the operational and financial performance for the fourth quarter and fiscal year 2026. The meeting is set to take place on May 25, 2026, at 12:00 PM IST.

The announcement was made in accordance with Regulation 30 and Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that no unpublished price sensitive information will be disclosed during the call.

Conference Call Details

The conference call will feature key management personnel who will address investors and analysts regarding the company's performance for the specified periods.

Participant Designation
Mr Rahul Nachane Managing Director
Mr Rajesh Lawande Whole-Time Director & Chief Financial Officer

Participation Information

Investors and analysts interested in joining the discussion can access the conference call via the provided toll-free numbers. The company has also provided a registration link for participants to join without waiting.

For further information regarding the conference call, stakeholders may contact Mr. Shivam Gharat, Company Secretary, or Mr. Abhishek Mehra, Investor Relations Advisor.

Historical Stock Returns for NGL Fine Chem

1 Day5 Days1 Month6 Months1 Year5 Years
+9.35%+20.43%+21.16%+102.95%+112.80%+46.38%

What revenue growth trajectory is NGL Fine Chem expected to report for FY2026, and how does it compare to industry peers in the specialty chemicals segment?

How might NGL Fine Chem's Q4 FY2026 margins be impacted by fluctuations in raw material costs and global API pricing pressures?

Will management provide any guidance on new product launches or capacity expansion plans that could drive growth in FY2027?

NGL Fine-Chem Limited Files SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 07 Apr 2026, 04:28 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

NGL Fine-Chem Limited submitted its mandatory SEBI compliance certificate for Q4FY26 on April 6, 2026, covering the quarter ended March 31, 2026. The certificate, issued by Purva Sharegistry (India) Pvt. Ltd., confirms proper handling of dematerialisation processes and adherence to regulatory timelines. Company Secretary Shivam Gharat filed the certificate with BSE Limited and National Stock Exchange, demonstrating the company's ongoing compliance with SEBI (Depositories and Participants) Regulations, 2018.

powered bylight_fuzz_icon
37061933

*this image is generated using AI for illustrative purposes only.

NGL Fine-Chem Limited has submitted its mandatory compliance certificate to stock exchanges for the quarter ended March 31, 2026. The pharmaceutical company filed the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 on April 6, 2026.

Regulatory Filing Details

The compliance certificate was submitted to both major Indian stock exchanges where the company's shares are listed. Company Secretary Shivam Gharat signed the submission letter on behalf of NGL Fine-Chem Limited.

Exchange Details: Information
BSE Limited: Scrip Code 524774
National Stock Exchange: Symbol NGLFINE
Filing Date: April 6, 2026
Quarter Covered: March 31, 2026

Certificate Confirmation

Purva Sharegistry (India) Pvt. Ltd., serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate on April 1, 2026. The certificate confirms adherence to SEBI regulations regarding dematerialisation processes during the quarter.

Compliance Parameters: Status
Securities Dematerialisation: Confirmed within timelines
Certificate Processing: Accepted/Rejected as per norms
Stock Exchange Listing: Maintained on existing exchanges
Register Updates: Completed within prescribed periods

Regulatory Compliance Framework

The certificate validates that securities received from depository participants for dematerialisation were properly processed during the quarter ended March 31, 2026. Purva Sharegistry confirmed that all security certificates were appropriately mutilated and cancelled after verification by depository participants.

Ms. Deepali Gaonkar, Compliance Officer at Purva Sharegistry, signed the confirmation certificate, ensuring that the company's register of members was updated with depositories' names as registered owners within prescribed timelines. This regulatory filing demonstrates NGL Fine-Chem Limited's continued compliance with SEBI's depositories and participants regulations.

Historical Stock Returns for NGL Fine Chem

1 Day5 Days1 Month6 Months1 Year5 Years
+9.35%+20.43%+21.16%+102.95%+112.80%+46.38%

How might NGL Fine-Chem's consistent regulatory compliance impact its eligibility for institutional investment or ESG-focused funds?

What operational or financial developments should investors expect from NGL Fine-Chem in the upcoming quarters following this compliance milestone?

Could this regulatory adherence signal NGL Fine-Chem's preparation for potential corporate actions like bonus issues or stock splits?

More News on NGL Fine Chem

1 Year Returns:+112.80%